These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 12756667)

  • 21. Myocardial injury in coronary artery bypass grafting: on-pump versus off-pump comparison by measuring high-sensitivity C-reactive protein, cardiac troponin I, heart-type fatty acid-binding protein, creatine kinase-MB, and myoglobin release.
    Chowdhury UK; Malik V; Yadav R; Seth S; Ramakrishnan L; Kalaivani M; Reddy SM; Subramaniam GK; Govindappa R; Kakani M
    J Thorac Cardiovasc Surg; 2008 May; 135(5):1110-9, 1119.e1-10. PubMed ID: 18455592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-sensitivity C-reactive protein for risk stratification in patients with heart failure.
    Bauters C; Lamblin N; de Groote P
    Am Heart J; 2008 Feb; 155(2):e7; author reply e9. PubMed ID: 18215583
    [No Abstract]   [Full Text] [Related]  

  • 23. Is high-sensitivity C-reactive protein associated with subclinical peripheral atherosclerosis?
    Paraskevas KI; Bessias N; Papas TT; Andrikopoulos V; Mikhailidis DP
    Angiology; 2009; 60(1):8-11. PubMed ID: 19190029
    [No Abstract]   [Full Text] [Related]  

  • 24. [C-reactive protein and risk of ischaemic vascular and cerebrovascular disease--secondary publication].
    Zacho J; Tybjaerg-Hansen A; Jensen JS; Grande P; Sillesen H; Nordestgaard BG
    Ugeskr Laeger; 2009 May; 171(21):1751-5. PubMed ID: 19492468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [C-reactive protein and atrial fibrillation. An old marker looking for a new target].
    Hernández Madrid A
    Rev Esp Cardiol; 2006 Feb; 59(2):94-8. PubMed ID: 16540029
    [No Abstract]   [Full Text] [Related]  

  • 26. New tool refines heart risk prediction. Adding C-reactive protein and family history modernizes and improves the standard risk tool.
    Harv Heart Lett; 2007 May; 17(9):4-5. PubMed ID: 17517984
    [No Abstract]   [Full Text] [Related]  

  • 27. [A commentary to the article by Dvoráková, Poledne: "An ultrasensitive C-reactive protein assay--a new parameter of a cardiovascular risk" sent from the Laboratory for Aterosclerosis Investigation at IKEM Prague].
    Málek F
    Vnitr Lek; 2004 Nov; 50(11):807-9. PubMed ID: 15648957
    [No Abstract]   [Full Text] [Related]  

  • 28. [CRP--a marker of a pro-inflammatory state and cardiovascular risk].
    Poledne R; Valenta Z; Pit'ha J
    Vnitr Lek; 2007 Apr; 53(4):391-5. PubMed ID: 17578172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel risk factors for heart disease. An interview with Gerald Gau, M.D.
    Gau G
    Mayo Clin Womens Healthsource; 2005 Jun; 9(6):S1-2. PubMed ID: 15888993
    [No Abstract]   [Full Text] [Related]  

  • 30. Finding the best heart treatment.
    Consum Rep; 2003 May; 68(5):9. PubMed ID: 12715784
    [No Abstract]   [Full Text] [Related]  

  • 31. [C-reactive protein--a molecule that changed cardiology].
    Ostádal P
    Vnitr Lek; 2004 Nov; 50(11):809-11. PubMed ID: 15648958
    [No Abstract]   [Full Text] [Related]  

  • 32. [Determination of C-reactive protein in cardiosurgery: importance in the postoperative monitoring of complications].
    Gaspardone A; Ciavolella M; Carlizzi G; Xagoraris V; Romeo F; Gioffrè PA
    Cardiologia; 1982 Dec; 27(12):1121-32. PubMed ID: 6892396
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of C-reactive protein on functional outcome in ischemic stroke patients.
    Ryu SR; Choi IS; Bian RX; Kim JH; Han JY; Lee SG
    Int J Neurosci; 2009; 119(3):336-44. PubMed ID: 19116840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C-reactive protein concentrations are lower in Singaporeans: implications for risk classification in Asians.
    Hawkins RC
    Clin Chim Acta; 2004 Dec; 350(1-2):241-2. PubMed ID: 15530485
    [No Abstract]   [Full Text] [Related]  

  • 35. [Cardiac troponin-I elevations after thoracic surgery. Incidence and correlations with baseline clinical characteristics, C-reactive protein and perioperative parameters].
    Lucreziotti S; Conforti S; Carletti F; Santaguida G; Meda S; Raveglia F; Tundo F; Panigalli T; Biondi ML; Mezzetti M; Fiorentini C
    Rev Esp Cardiol; 2007 Nov; 60(11):1159-66. PubMed ID: 17996176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utility of C-reactive protein measurement in risk stratification during primary cardiovascular disease prevention.
    Bard RL; Rubenfire M; Eagle K; Clarke NS; Brook RD
    Am J Cardiol; 2005 Jun; 95(11):1378-9. PubMed ID: 15904650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A better way to predict cardiovascular risk. We know how important cholesterol levels are, but what about inflammation?
    Harv Womens Health Watch; 2007 Apr; 14(8):1-2. PubMed ID: 17441261
    [No Abstract]   [Full Text] [Related]  

  • 38. The biology, utilization, and attenuation of C-reactive protein in cardiovascular disease: part II.
    Armani A; Becker RC
    Am Heart J; 2005 Jun; 149(6):977-83. PubMed ID: 15976778
    [No Abstract]   [Full Text] [Related]  

  • 39. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
    Goei D; Hoeks SE; Boersma E; Winkel TA; Dunkelgrun M; Flu WJ; Schouten O; Bax JJ; Poldermans D
    Coron Artery Dis; 2009 May; 20(3):219-24. PubMed ID: 19322079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Why does C-reactive protein predict coronary events?
    Kushner I; Elyan M
    Am J Med; 2008 Jul; 121(7):e11. PubMed ID: 18589040
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.